UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE OR INTOLERANCE TO BIOLOGICAL DMARDS: RESULTS AT 60 WEEKS FROM THE SELECT-BEYOND STUDY Genovese, M. C., Combe, B., Hall, S., Rubbert-Roth, A., Zhong, S., Meerwein, S., Pangan, A., Fleischmann, R. BMJ PUBLISHING GROUP. 2019: 360–61

View details for DOI 10.1136/annrheumdis-2019-eular.2285

View details for Web of Science ID 000472207101081